In this episode, we’re diving into one of the most transformative frontiers in biotechnology — gene editing. My guest is Jack Crawford, CEO of Demeetra, a company pioneering the next generation of gene editing technologies designed for real-world impact.

Demeetra’s mission is simple yet ambitious — to make gene editing accessible, scalable, and commercially viable across healthcare, biotechnology, and agriculture.

Listen to explore how Demeetra is helping global innovators bring genetic breakthroughs from lab to life — and the leadership vision driving it all.